Stay updated on Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page
- Check6 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA notice about the NIH website terminology transition appears above the page, and the site revision updates from v3.7.1 to v3.7.2. The study page continues to display a 403 error.SummaryDifference1%

- Check34 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check48 days agoChange DetectedThe NiTraSarc study page now shows a 403 Forbidden error with a minimal header and a Home link; the detailed study content is no longer visible, leaving an error screen as the primary content.SummaryDifference19%

- Check55 days agoChange DetectedRevision: v3.7.0 is now shown on the page, replacing v3.6.6. This indicates a software/content update to the Study Details page without altering the underlying study data.SummaryDifference0.1%

- Check69 days agoChange DetectedFooter revision label updated from Revision: v3.6.5 to Revision: v3.6.6, representing a minor page update. It does not indicate changes to the study content or data.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.